Exploiting LH in ovarian stimulation

Reproductive BioMedicine Online

Volumn 12, Issue 2, 2006, Pages 221-233

  Alviggi, Carlo ^a   Mollo, A ^a   Clarizia, R ^a   De Placido, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Assisted reproductive techniques; Ceiling; LH; Ovarian stimulation; Recombinant gonadotrophin; Threshold

Indexed keywords

BUSERELIN; CLOMIFENE CITRATE; ESTRADIOL; GONADORELIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; METFORMIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ANOVULATION; ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG RESPONSE; ESTRADIOL BLOOD LEVEL; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY; INFERTILITY THERAPY; INTERVENTION STUDY; LOW DRUG DOSE; MATERNAL AGE; MENSTRUATION DISORDER; META ANALYSIS; OBSERVATIONAL STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; SPONTANEOUS ABORTION; STEROIDOGENESIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 33144485636     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60865-6     Document Type: Review

References (77)

1. 15 Thr LH-beta variant undergoing controlled ovarian stimulation. Abstracts of the 21st Annual Meeting of ESHRE. Human Reproduction 20 (suppl. 1), P-385, i139.
2. Balasch J, Vidal E, Penarrubia J et al. 2001 Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Human Reproduction 16, 1636-1643.
3. Chappel SC, Howles C 1991 Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Human Reproduction 6,1206-1212.
4. de Castro F, Moron FJ, Montoro L et al. 2004 Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics 14,285-293.
5. De Placido G, Alviggi C, Perino A et al. 2005 Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Human Reproduction 20, 390-396.
6. De Placido G, Alviggi C, Mollo A et al. 2004 Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clinical Endocrinology (Oxford) 60, 637-643.
7. De Placido G, Mollo A, Alviggi C et al. 2001 Rescue of IVF cycles by MIG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Human Reproduction 16,1875-1879.
8. Elder K, Dale B (eds) 2000 Producing gametes. In: In Wtro Fertilization. Cambridge University Press, Cambridge, pp. 8-33.
9. Erickson GF, Wang C, Hsueh AJW 1979 FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature 279, 336-338.
10. Esposito MA, Barnhart KT, Coutifaris C et al. 2001 Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertility and Sterility 75,519-524.
11. European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone. 2002 Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial. Fertility and Sterility 78, 520-528.
12. Fair T 2003 Follicular oocyte growth and acquisition of developmental competence. Animal Reproduction Science 78, 203-216.
13. Ferraretti AP, Gianaroli L, Magli MC et al. 2004 Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertility and Sterility 82, 1521-1526.
14. Fevold H 1941 Synergysm of follicle stimulating and luteinizing hormones in producing estrogen secretion. Endocrinology 28, 33-36.
15. Filicori M, Cognigni GE, Pocognoli P et al. 2003a Current concepts and novel applications of LH activity in ovarian stimulation. Trends in Endocrinology and Metabolism 14, 267-273.
16. Filicori M, Cognigni GE, Ciampaglia W 2003b What clinical evidence for an LH ceiling? Human Reproduction 18, 1556-1557.
17. Filicori M, Cognigni GE, Taraborrelli S et al. 2002a Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertility and Sterility 78, 414-416.
18. Filicori M, Cognigni GE, Tabarelli C et al. 2002b Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. Journal of Clinical Endocrinology and Metabolism 87, 1156-1161.
19. Filicori M, Cognigni GE, Taraborrelli S et al. 1999 Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. Journal of Clinical Endocrinology and Metabolism 84, 2659-2663.
20. Fleming R, Lloyd F, Herbert M et al. 1998 Effects of profound suppression of luteinizing hormone during ovarian stimulation on fullicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Human Reproduction 13, 1788-1792.
21. Giudice E, Crisci C, Altarocca V et al. 2001 Characterisation of a partially purified human menopausal gonadotropin preparation. Journal of Clinical Research 4, 27-34.
22. Hemsey G, O'Brien F, O'Dea L 2001 Objective evidence of LH dependence in women with profound LH and FSH deficiency. Abstracts of the 57th Annual Meeting of the American Society for Reproductive Medicine. Fertility and Sterility 76 (Suppl. 3), S208 (P-292).
23. Hillier SG 1987 Intrafollicular paracrine function of ovarian androgen. Journal of Steroids Biochemistry 27, 351-357.
24. Hillier SG, Whitelaw PF, Smyth CD 1994 Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Molecular and Cellular Endocrinology 100, 51-54.
25. Hillier SG, Van Den Boogard AMJ, Reichert LE et al. 1980 Intraovarian sex steroids hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro. Journal of Clinical Endocrinology and Metabolism 50, 640-647.
26. Homburg R, Armar NA, Eshel A et al. 1988 Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 22, 1024-1026.
27. Howles CM, Macramee MC, Edwards RG et al. 1986 Effect of high tonic concentrations of luteinising hormone on outcome of in-vitro fertilisation. Lancet 30, 521-522.
28. Huang ZH, Clayton PE, Brady G et al. 1994 Insulin-like growth factor-I gene expression in human granulosa-lutein cells. Journal of Molecular Endocrinology 12, 283-291.
29. Hughes EG, Fedorkow DM, Daya S et al. 1992 The routine use of gonadotrophin-releasing hormone agonists prior to in vitro fertilisation and gamete intrafallopian transfer: a meta-analysis of randomised controlled trials. Fertility and Sterility 58, 888-896.
30. Hugues JN, Soussis J, Calderon I et al. 2005 Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study. Human Reproduction 20, 629-635.
31. Huhtaniemi I, Jiang M, Nilsson et al. 1999 Mutations and polymorphisms in gonadotropin genes. Molecular and Cellular Endocrinology 25, 89-94.
32. Humaidan P, Bungum M, Bungum L et al. 2004 Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reproductive BioMedicine Online 6, 635-643.
33. Humaidan P, Bungum L, Bungum M et al. 2002 Ovarian response and pregnancy outcome related to mid-follicular LH concentrations in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Human Reproduction 17, 2016-2021.
34. Hurwitz JM, Santoro N 2004 Inhibins, activins, and follistatin in the aging female and male. Seminars in Reproductive Medicine 22, 209-217.
35. Jakubowicz DJ, Iuorno MJ, Jakubowicz S et al. 2002 Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87, 524-529.
36. Jia X-C, Kessel B, Welsh TH et al. 1985 Androgen inhibition of follicle-stimulating hormone-stimulated luteinizing hormone receptor formation in cultured rat granulosa cells. Endocrinology 117, 13-22.
37. Jiang M, Pakarinen P, Zhang FP et al. 1999 A common polymotphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence. Human Molecular Genetics 8, 2037-2046.
38. Kolibianakis EM, Zikopoulos K, Schiettecatte J et al. 2004 Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Human Reproduction 19, 2490-2496.
39. Laven JS, Imani B, Eijkemans MJ et al. 2002 New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstetrical and Gynecological Survey 57, 755-767.
40. le Cotonnec JY, Porchet HC, Beltrami V et al. 1998a Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertility and Sterility 69, 189-194.
41. le Cotonnec JY, Porchet HC, Beltrami V et al. 1998b Clinical pharmacology of recombinant human luteinizing hormone: part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. Fertility and Sterility 69, 195-200.
42. Lisi F, Rinaldi L, Fishel S et al. 2001 Use of recombinant FSH and recombinant LH in multiple follicular stimulation for IVF: a preliminary study. Reproductive BioMedicine Online 3, 190-194.
43. Loumaye E, O'Dea L 2002 Recombinant human luteinizing hormone: a review. In: Tarlatzis B (ed.), European Practice in Gynaecology and Obstetrics: Ovulation Induction. Elsevier, Paris, pp. 197-208.
44. Loumaye E, Engrand P, Shoham Z et al. 2003a Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Human Reproduction 18, 314-322.
45. Loumaye E, Engrand P, Shoham Z et al. 2003b Clinical evidence for an LH ceiling? Human Reproduction 18, 2719-2720.
46. Magoffin DA 2003 Ovarian theca cell. International Journal of Biochemistry and Cell Biology 37, 1344-1349.
47. Marrs R, Meldrum D, Muasher S et al. 2004 Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reproductive BioMedicine Online 8, 175-182.
48. McNatty KP, Makris A, Reinhold VN et al. 1979 Metabolism of androstenedione in human ovarian tissues in vitro with particular reference to reductase and aromatase activity. Steroids 34, 429-443.
49. Mitchell R, Hollis S, Rothwell C et al. 1995 Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive. Clinical Endocrinology 42, 501-507.
50. Nestler JE, Stovall D, Akhter N et al. 2002 Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertility and Sterility 77, 209-215.
51. Nilsson C, Pettersson K, Millar RP et al. 1997 Frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group. Fertility and Sterility 67, 998-1004.
52. Pellicer A, Miro F, Sampaio M et al. 1991 In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertility and Sterility 55, 970-975.
53. Pettersson K 1994 Genetic polymorphism found in the LH anomalous variant of human luteinizing hormone. European Journal of Endocrinology Suppl 2, 65.
54. Platteau P, Smitz J, Albano C et al. 2004 Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. Fertility and Sterility 81, 1401-1404.
55. Rabinovici J, Blankstein J, Goldman B et al. 1989 In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. Journal of Clinical Endocrinology and Metabolism 68,693-697.
56. Ramanujam LN, Liao WX, Roy AC et al. 1999 Association of molecular variants of luteinizing hormone with menstrual disorders. Clinical Endocrinology (Oxford) 51, 243-246.
57. Regan L, Owen EJ, Jacobs HS 1990 Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet 336, 1141-1144.
58. Ropelato MG, Garcia-Rudaz MC, Castro-Fernandez C et al. 1999 A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 84, 4629-4636.
59. Shetty G, Krishnamurthy H, Krishnamurthy HN et al. 1997 Effect of estrogen deprivation on the reproductive physiology of male and female primates. Journal of Steroid Biochemistry and Molecular Biology 61, 57-66.
60. Shima K, Kitayama S, Nakano R 1987 Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstetrics and Gynecology 69, 800-806.
61. Shoham Z, Schacter M, Loumaye E et al. 1995 The luteinizing hormone surge - the final stage in ovulation induction: modern aspects of ovulation triggering. Fertility and Sterility 64, 237-251.
62. Shoham Z, Borenstein R, Lunenfeld B et al. 1990 Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clinical Endocrinology (Oxford) 33, 271-278.
63. Sills ES, Levy DP, Moomjy M et al. 1999 A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Human Reproduction 14, 2230-2235.
64. Simoni M, Nieschlag E, Gromoll J 2002 Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Human Reproduction Update 8, 413-421.
65. Smyth CD, Miro F, Whitelaw PF et al. 1993 Ovarian thecal/interstitial androgen synthesis is enhanced by a follicle-stimulating hormone-stimulated paracrine mechanism. Endocrinology 133, 1532-1538.
66. Stanger JD, Yovich JL 1985 Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone concentrations during the follicular phase. British Journal of Obstetrics and Gynaecology 92, 385-393.
67. Stokman PG, de Leeuw R, van den Wijngaard HA et al. 1993 Human chorionic gonadotropin in commercial human menopausal gonadotropin preparation. Fertility and Sterility 60, 175-178.
68. Themmen APN, Huhtaniemi IT 2000 Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 21,551-583.
69. van Santbrink EJ, Fauser BC 1997 Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. Journal of Clinical Endocrinology and Metabolism 82, 3597-3602.
70. Van Wely M, Westergaard LG, Bossuyt PM et al. 2003 Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews 1, CDO03973.
71. Westergaard LG, Erb K, Laursen SB et al. 2001 Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertility and Sterility 76, 543-549.
72. Wastergaard LG, Laursen SB, Andersen CY 2000 Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction 15, 1003-1008.
73. Willis DS, Watson H, Mason HD et al. 1998 Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. Journal of Clinical Endocrinology and Metabolism 83, 3984-3991.
74. Zeleznik AJ, Hillier SG 1984 The role of gonadotropins in the selection of the preovulatory follicle. Clinical Obstetrics and Gynecology 27, 927-940.
75. Zelinski-Wooten MB, Hess DL, Wolf DP et al. 1994 Steroid reduction during ovarian stimulation impairs oocyte fertilization, but not folliculogenesis, in rhesus monkeys. Fertility and Sterility 61, 1147-1155.
76. Zelinski-Wooten MB, Hess DL, Baughman WL et al. 1993 Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. Journal of Clinical Endocrinology and Metabolism 76, 988-995.
77. Zhou J, Bondy C 1993 Anatomy of the human ovarian insulin-like growth factor system. Biology of Reproduction 48, 467-482.